A little help keeping your community in the loop. Good stories, good company.

Explore News.ggDiscord news bot World news for Discord Gaming news and patch notes RSS feeds for Discord Stock market alerts

Blog & GuidesNews.gg Blog Crypto News & Alerts Stock Market News Bots Gaming News Bots Setup Crypto Alerts Stocks Video Guide

ProductFeatures Dashboard Pricing Support

ResourcesBlog Help & Support Discord Server Twitter / X Changelog Developer API

CompanyCommunities Careers Log In Contact

LegalPrivacy Policy Terms of Service Cookie Policy

FDA adds rare vision-loss warning to popular GLP-1 drugs | News.gg

Wednesday, November 11, 2026Coverage from every side, on News.ggInternational Edition

News.gg

Home Latest Off the Radar

Subscribe Login

Published 2 days ago · Inquirer.com · Updated 2 days ago

Off the radar: covered mostly by the left

FDA adds rare vision-loss warning to popular GLP-1 drugs

Side-by-Side Framing

The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, such as Ozempic

Summary from the original article

Inquirer.comFactualityFactuality is a Premium featureHow reliably the outlets covering this story report facts, based on their track record of accuracy and corrections.

Lean LeftLean LeftBased on the outlet's overall lean; article framing check pending

The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, such as Ozempic

By MATTHEW PERRONE · Nov 9, 2026, 8:20 PM UTC

Read full article at Inquirer.com

Side-by-Side Framing

Premium

AI key points, how left, center and right framed this story, tone by side and loaded language are part of News.gg Premium.

Upgrade this server

1 Article

Inquirer.comFactualityLean Left
FDA adds rare vision-loss warning to popular GLP-1 drugs
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, such as Ozempic
2 days ago · inquirer.com · You are reading this one

Coverage Details

Total News Sources: 3
Leaning Left: 3
Leaning Right: 0
Center: 0
Last Updated: 2 days ago
Bias Distribution: 100% Left

Bias Distribution

• 100% of the sources are Left

L 100%

Inquirer.comLean Left · inquirer.com

Factuality

To view factuality data please Upgrade to Premium

Bias ratings are News.gg assessments of each article's wording compared with other outlets covering the same story.